TrialAntimicrobial agents and chemotherapy2017

Molecular β-Lactamase Characterization of Aerobic Gram-Negative Pathogens Recovered from Patients Enrolled in the Ceftazidime-Avibactam Phase 3 Trials for Complicated Intra-abdominal Infections, with Efficacies Analyzed against Susceptible and Resistant Subsets.

Rodrigo E Mendes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.